# WEST PHARMACEUTICAL SERVICES, INC. (WST) FY2026 Q2 Balance Sheet

- Company: WEST PHARMACEUTICAL SERVICES, INC. (WST)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0000105770-26-000099
- Page: https://plicit.ai/financials/wst/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/wst-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 4,076,400,000 US dollars
- **Current assets**: 1,807,500,000 US dollars
- **Non-current assets**: 2,268,900,000 US dollars
- **Liabilities**: 1,086,200,000 US dollars
- **Current liabilities**: 640,500,000 US dollars
- **Non-current liabilities**: 445,700,000 US dollars
- **Equity**: 2,990,200,000 US dollars
- **Property, plant and equipment**: 3,248,600,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.
- **Less: accumulated depreciation and amortization**: negative 1,562,300,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.
- **Accounts receivable, net**: 712,000,000 US dollars
- **Inventories**: 447,400,000 US dollars
- **Cash and cash equivalents**: 435,800,000 US dollars
- **Other current assets**: 212,300,000 US dollars
- **Property, plant and equipment, net**: 1,686,300,000 US dollars
- **Investments in affiliated companies**: 207,700,000 US dollars
- **Goodwill**: 108,700,000 US dollars
- **Operating lease right-of-use assets**: 104,700,000 US dollars
- **Other noncurrent assets**: 82,800,000 US dollars
- **Deferred income taxes**: 72,300,000 US dollars
- **Intangible assets, net**: 6,400,000 US dollars
- **Accounts payable**: 252,700,000 US dollars
- **Other current liabilities**: 171,100,000 US dollars
- **Accrued salaries, wages and benefits**: 97,100,000 US dollars
- **Income taxes payable**: 64,700,000 US dollars
- **Accrued commissions, rebates and royalties**: 34,000,000 US dollars
- **Operating lease liabilities**: 20,900,000 US dollars
- **Long-term debt**: 202,900,000 US dollars
- **Other long-term liabilities**: 89,900,000 US dollars
- **Operating lease liabilities**: 88,300,000 US dollars
- **Pension and other postretirement benefits**: 28,300,000 US dollars
- **Deferred income taxes**: 22,400,000 US dollars
- **Deferred compensation benefits**: 13,900,000 US dollars
- **Retained earnings**: 4,624,100,000 US dollars
- **Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: June 30, 2026 - 75.3 million, December 31, 2025 - 75.3 million; shares outstanding: June 30, 2026 - 70.4 million, December 31, 2025 - 72.0 million**: 18,800,000 US dollars
- **Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding**: 0 US dollars
- **Capital in excess of par value**: 0 US dollars
- **Treasury stock, at cost (June 30, 2026 - 4.9 million shares, December 31, 2025 - 3.3 million shares)**: negative 1,512,300,000 US dollars
- **Accumulated other comprehensive loss**: negative 140,400,000 US dollars
- **Gross equity (calculated)**: 4,642,900,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.